Biotech

Mesoblast Limited (ASX:MSB) "The Year in Review" Address By Chairman Brian Jamieson

🕔11/28/2008 1:27:59 PM

Today I would like to present you with a snapshot of the considerable achievements made by Mesoblast in the 2008 financial year, achievements that cannot be underestimated as the Company moves closer to productisation of its unique adult stem cell platform technology. Later in this meeting, our Executive Director, Professor Silviu Itescu, will detail our progress and plans towards becoming a market leader in our core activities.

Read Full Article▸

Benitec Limited (ASX:BLT) Benitec US Re-exam Further Update

🕔11/28/2008 1:22:59 PM

The Directors of Benitec Limited (ASX:BLT)(PINK:BNIKF) provide the following update on the US patent re-examination of the '099 Graham patent.

Read Full Article▸

Benitec Limited (ASX:BLT) Update On The US Patent Re-examination Of The '099 Graham Patent

🕔11/21/2008 9:59:38 AM

The Directors of Benitec Limited (ASX:BLT)(PINK:BNIKF) provide the following update on the US patent re-examination of the '099 Graham patent.

Read Full Article▸

Benitec Limited (ASX:BLT) Announces Prudent Cash Management Strategy

🕔11/20/2008 10:37:18 AM

Leading developer of RNA interference (RNAi)-based therapeutics Benitec Limited (ASX:BLT)(PINK:BNIKF) announced today that it has, with immediate effect, implemented steps to further reduce its cash burn. These measures are designed to guarantee that the Company maintains sufficient funding to finance its near term key activities including ongoing negotiations with CSIRO, IP prosecution and maintenance and the City of Hope collaboration.

Read Full Article▸

Benitec Limited (ASX:BLT) Chairman's Address To Shareholders

🕔11/19/2008 10:14:02 AM

We have successfully strengthened the Benitec team during the past year. Our CEO Sue MacLeman was appointed a Director of the Company and Mel Bridges joined the Board as a Non-Executive Director. We also appointed Dr Jason Smythe as Chief Scientific Officer.

Read Full Article▸

Biota Holdings Limited (ASX:BTA) LANI Phase III Clinical Trials Set For Enrolment

🕔11/17/2008 12:02:03 PM

Biota Holdings Limited (ASX:BTA)(PNK:BTAHY) today announced that the multiple centres involved in the Phase III clinical trail on its long acting neuraminidase inhibitor (LANI) CS-8958 are ready to commence treatment. Patients are expected to enrol into the study progressively throughout the Asian influenza season.

Read Full Article▸

Starpharma Holdings Limited (ASX:SPL) AGM - Address To Shareholders By Chairman Peter T. Bartels

🕔11/14/2008 1:53:28 PM

Attached is the Chairman's address to the Annual General Meeting of Starpharma Holdings Limited (ASX:SPL, OTCQX:SPHRY), to be held at 4.00pm today.

Read Full Article▸

Banking & Finance

Read More

Oil Gas & Energy

Read More

Life Sciences

Read More

Social Media

Latest Headlines